Trials / Not Yet Recruiting
Not Yet RecruitingNCT04730024
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results From the K0104 Extension Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (estimated)
- Sponsor
- Kang Stem Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, open, long-term follow-up study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results from the K0104 Extension Study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable(observational study) | Not applicable(observational study) |
Timeline
- Start date
- 2022-03-27
- Primary completion
- 2030-06-30
- Completion
- 2030-06-30
- First posted
- 2021-01-29
- Last updated
- 2021-01-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04730024. Inclusion in this directory is not an endorsement.